CD55 抗体 (AA 301-381)
Quick Overview for CD55 抗体 (AA 301-381) (ABIN731228)
抗原
See all CD55 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 301-381
-
交叉反应
- 人
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human CD55
-
亚型
- IgG
-
-
-
-
应用备注
-
ELISA 1:500-1000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
有效期
- 12 months
-
-
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
别名
- CD55/DAF
-
背景
-
Synonyms: CR, TC, DAF, CROM, Complement decay-accelerating factor, CD55
Background: This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade.
-
基因ID
- 1604
-
UniProt
- P08174
-
途径
- Complement System, Regulation of Leukocyte Mediated Immunity
抗原
-